The Global Alliance for TB Drug Development has launched a clinical trial to test a novel three-drug regime for tuberculosis which, it says, shows promise for treating both drug-sensitive and multidrug-resistant forms of the disease. ---Subscribe to MedNous to access this article--- Research & University News
